Access cutting-edge non-hodgkin lymphoma treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access non-hodgkin lymphoma specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-hodgkin lymphoma treatment provided free
This study is researching an investigational drug, odronextamab, in adult patients B-cell non-Hodgkin's lymphoma (B-NHL). The main purpose of this study is to assess the effectiveness of odronextamab in destroying cancer cells and to learn more about the safety of odronextamab. The study is looking at several other research questions, including: * To see if odronextamab works to destroy cancer cells * Side effects that may be experienced by people taking odronextamab * How odronextamab works
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this non-hodgkin lymphoma clinical trial in Chicago, IL
If you're searching for non-hodgkin lymphoma treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-hodgkin lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.